The present invention relates to fused bicyclic metalloproteinase inhibitors
of the formula
##STR1##
wherein A, B, X, Y, and R1 are as defined in the specification,
and to pharmaceutical compositions and methods of treating arthritis, inflammation,
cancer and other disorders.
